Australian cancer treatment firm Sirtex accepts $1.4b offer from China’s CDH

Photo: Sirtex Medical

Liver cancer treatment firm Sirtex Medical Ltd said on Thursday its board has recommended an offer from China’s CDH Investments to buy the firm for A$1.87 billion ($1.41 billion).

Continue reading this story with a subscription to DealStreetAsia.


Should your colleagues be reading this article too? Contact us for corporate subscriptions at